Clinical Trial Update: Study in Healthy Adults Evaluating PF-07202954 [Phase 1]

View source ↗

Summary

Pfizer completed a Phase 1 study in healthy adults evaluating PF-07202954 for potential application in non-alcoholic fatty liver disease and liver fibrosis; res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Fibrosis
• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• PF-07202954

Snippet

Sponsor: Pfizer | Conditions: Non-Alcoholic Fatty Liver Disease, Liver Fibrosis | Phase 1 | Status: COMPLETED | Results posted: 2024-09-20